Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an article by Hasan Cagri Yildirim, et al. on LinkedIn:
“Excited to share our latest publication: “A Narrative Review of RAS Mutations in Early-Stage Colorectal Cancer: Mechanisms and Clinical Implications”.
Our review explores the prognostic and clinical significance of KRAS mutations in early-stage colorectal cancer (CRC), particularly in MSS tumors. Findings highlight the need for routine molecular profiling to refine risk stratification and guide adjuvant therapy decisions.
Read more.”
A Narrative Review of RAS Mutations in Early-Stage Colorectal Cancer: Mechanisms and Clinical Implications.
Authors: Hasan Cagri Yildirim, et al.
